Discover
NMTC
NeuroOne Medical Technologies Corporation
1.61
1 x 1.53
1 x 1.70
bid
ask
+
0.05
3.21%
12:27 PM
timesize
| Ytd | -64.62% | |
| 1y | -63.66% |
1.58
day range
1.66
1.42
52 week range
6.96
| Open | 1.66 | Prev Close | 1.56 | Low | 1.58 | High | 1.66 | Mkt Cap | 14.01M |
| Vol | 28.72K | Avg Vol | 45.71K | EPS | -0.51 | P/E | -3.16 | Forward P/E | -2.65 |
| Beta | 0.61 | Short Ratio | 0.60 | Inst. Own | 19.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.70 | 200-d Avg | 4.08 | 1yr Est | 3.15 |
| Income Statement | |||
| Total Revenue | 1.86M | ||
| Revenues (USD) | 1.86M | ||
| Cost of Revenue | 871.79K | ||
| Gross Profit | 990.26K | ||
| Operating Expenses | 3.39M | ||
| Research and Development Expense | 1.47M | ||
| Selling, General and Administrative Expense | 1.92M | ||
| Operating Income | -2.40M | ||
| Net Income | -2.38M | ||
| Net Income Common Stock | -2.38M | ||
| Net Income Common Stock (USD) | -2.38M | ||
| Consolidated Income | -2.38M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -2.38M | ||
| Earning Before Interest & Taxes (USD) | -2.38M | ||
| Weighted Average Shares | 8.48M | ||
| Weighted Average Shares Diluted | 8.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.80M | ||
| Cash and Equivalents (USD) | 2.80M | ||
| Trade and Non-Trade Receivables | 1.90M | ||
| Current Assets | 7.11M | ||
| Property, Plant & Equipment Net | 427.37K | ||
| Total Assets | 7.57M | ||
| Total Debt | 92.36K | ||
| Current Liabilities | 1.69M | ||
| Debt Non-Current | 92.36K | ||
| Total Liabilities | 2.49M | ||
| Accumulated Retained Earnings (Deficit) | -82.43M | ||
| Shareholders Equity | 5.08M | ||
| Shareholders Equity (USD) | 5.08M | ||
| Assets Non-Current | 461.16K | ||
| Total Debt (USD) | 92.36K | ||
| Goodwill and Intangible Assets | 33.79K | ||
| Inventory | 2.10M | ||
| Liabilities Non-Current | 801.87K | ||
| Trade and Non-Trade Payables | 934.20K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 89.51K | ||
| Net Cash Flow from Financing | 609.62K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -757.60K | ||
| Capital Expenditure | -38.52K | ||
| Issuance (Purchase) of Equity Shares | 609.62K | ||
| Net Cash Flow from Investing | -38.52K | ||
| Net Cash Flow from Operations | -1.33M | ||
| Share Based Compensation | 342.14K | ||